{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T05:22:37Z","timestamp":1711430557148},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,30]]},"DOI":"10.7759\/cureus.14783","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T05:23:27Z","timestamp":1619846607000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of Toxic Epidermal Necrolysis Caused by the Use of Trimethoprim Alone"],"prefix":"10.7759","author":[{"given":"Mala","family":"Sood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samson O","family":"Oyibo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeyanthy","family":"Rajkanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8654-z","article-title":"Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Lerch M","year":"2018","unstructured":"Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018, 54:147-76. 10.1007\/s12016-017-8654-z","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14530","article-title":"U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer D","year":"2016","unstructured":"Creamer D, Walsh SA, Dziewulski P, et al.. U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br J Dermatol. 2016, 174:1194-227. 10.1111\/bjd.14530","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.01.031","article-title":"the epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis\u00a0in the UK","volume":"137","author":"Frey N","year":"2017","unstructured":"Frey N, Jossi J, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J. the epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis\u00a0in the UK. J Invest Dermatol. 2017, 137:1240-7. 10.1016\/j.jid.2017.01.031","journal-title":"J Invest Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1071","article-title":"The medication risk of stevens-johnson Syndrome and Toxic epidermal necrolysis in Asians: the major drug causality and comparison with the US FDA Label","volume":"105","author":"Wang YH","year":"2019","unstructured":"Wang YH, Chen CB, Tassaneeyakul W, et al.. The medication risk of stevens-johnson Syndrome and Toxic epidermal necrolysis in Asians: the major drug causality and comparison with the US FDA Label. Clin Pharmacol Ther. 2019, 105:112-20. 10.1002\/cpt.1071","journal-title":"Clin Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau JC","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, et al.. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995, 333:1600-7. 10.1056\/NEJM199512143332404","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients","volume":"123","author":"Revuz J","year":"1987","unstructured":"Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Wechsler J, Touraine R. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol. 1987, 123:1160-5.","journal-title":"Arch Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-203163","article-title":"A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole","volume":"2014","author":"Rijal JP","year":"2014","unstructured":"Rijal JP, Pompa T, Giri S, Bhatt VR. A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole. BMJ Case Rep. 2014, 2014:10.1136\/bcr-2013-203163","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin S","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000, 115:149-53. 10.1046\/j.1523-1747.2000.00061.x","journal-title":"J Invest Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1203475420982550","article-title":"Retrospective study of patients with SJS\/TEN treated at a tertiary burn unit in Canada: overview of 17 years of treatment","author":"Olteanu C","year":"2021","unstructured":"Olteanu C, Shear NH, Burnett M, Hashimoto R, Jeschke MG, Ziv M, Dodiuk-Gad RP. Retrospective study of patients with SJS\/TEN treated at a tertiary burn unit in Canada: overview of 17 years of treatment. J Cutan Med Surg. 2021, 1203475420982550. 10.1177\/1203475420982550","journal-title":"J Cutan Med Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6627.970","article-title":"Toxic epidermal necrolysis occurring during treatment with trimethoprim alone","volume":"296","author":"Nwokolo C","year":"1988","unstructured":"Nwokolo C, Byrne L, Misch KJ. Toxic epidermal necrolysis occurring during treatment with trimethoprim alone. Br Med J (Clin Res Ed). 1988, 296:970. 10.1136\/bmj.296.6627.970","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6636.1604-e","article-title":"Drug points: toxic epidermal necrolysis and trimethoprim","volume":"296","author":"Das G","year":"1988","unstructured":"Das G, Bailey MJ, Wickham JE. Drug points: toxic epidermal necrolysis and trimethoprim. Br Med J (Clin Res Ed). 1988, 296:1604-5. 10.1136\/bmj.296.6636.1604-e","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79382-X","article-title":"Arthritis, uveitis, and Stevens-Johnson syndrome induced by trimethoprim","volume":"351","author":"Arola O","year":"1998","unstructured":"Arola O, Peltonen R, Rossi T. Arthritis, uveitis, and Stevens-Johnson syndrome induced by trimethoprim. Lancet. 1998, 351:1102. 10.1016\/S0140-6736(05)79382-X","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/57551-a-case-of-toxic-epidermal-necrolysis-caused-by-the-use-of-trimethoprim-alone","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:01Z","timestamp":1707507181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/57551-a-case-of-toxic-epidermal-necrolysis-caused-by-the-use-of-trimethoprim-alone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.14783","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,30]]}}}